Free tool
FAERS Monitor: Tis-U-Sol
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018508 or its brand name (Tis-U-Sol, Magnesium Sulfate, Potassium Chloride, Potassium Phosphate, Monobasic, Sodium Chloride, Sodium Phosphate). Reports on generic versions are filed under their own applications.
Reports
1
Serious
1
100% of reports
Hospitalization
1
Death reported
0
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- abdominal distension1
- abnormal faeces1
- dehydration1
- device leakage1
- faeces discoloured1
- food intolerance1
- vomiting1
- wrong drug administered1
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2010 | 1 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,158 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| food intolerance | 1 | 5744.7 | 5561.7 | 1,435 |
| abnormal faeces | 1 | 2567.3 | 2512.3 | 641 |
| wrong drug administered | 1 | 2360.3 | 2311.9 | 589 |
| faeces discoloured | 1 | 970.5 | 957.7 | 242 |
| device leakage | 1 | 485.1 | 480.6 | 121 |
| abdominal distension | 1 | 201.5 | 200.3 | 50 |
| dehydration | 1 | 157.7 | 156.9 | 39 |
| vomiting | 1 | 44.7 | 44.6 | 10 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.